UnitedHealth Shares Slide as Medicare Advantage Crackdown Signal Weighs on Sector
· 6 sources
UnitedHealth leads a sector sell-off after a government signal on Medicare Advantage fraud and an audit proposal, according to several outlets.
What happened
UnitedHealth Group (UNH) shares kept falling on Nov 19 after the government signaled a crackdown on Medicare Advantage fraud, MarketWatch reports. Seeking Alpha says the company led a sell-off across its sector on the Medicare fraud news.
TIKR.com reports the stock dropped 14% in a week on a Medicare audit proposal from CMS. TradingKey puts the move on Nov 19 at 5.05% lower.
Traders Union describes downward momentum dominating below the $295.12 support level. Separately, TIKR.com reports that George Soros and 26 other big funds sold UnitedHealth last quarter while 12 bought, noting that the largest purchase by dollar value went the other way.
Context
Medicare Advantage is a government-linked health insurance program run through private insurers, so changes in federal oversight can affect the companies that offer it.
Why it matters
The episode shows how regulatory scrutiny of Medicare Advantage can influence sentiment toward UnitedHealth and other health insurers.
Stocks in this story
Price changes are shown for the trading day of the story and are a coincidence in time, not proof that the news caused them. Figures are ATLAS data from our database.
$405.91Fair range: $365.32 to $446.50The price ($333.78) is 17.8% below that figure.
Chance of a rise in 1 month
49%Probability of closing higher than today within 21 sessions.Normal range: half of the scenarios end between $306.41 and $360.99; 9 in 10, between $264.97 and $417.45.
Fair value, probabilities and earnings for every stock. Free account, no card. Information, not advice.
Information, not advice. This content is informational and is not an investment recommendation or an offer to buy or sell securities. ATLAS estimates come from statistical models using public data, can be wrong, and past performance does not guarantee future results. Disclaimer
ATLAS Signals
ATLAS Signals, every week
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy